The 2025 CDTR Pilot & Feasibility Application Cycle is Now Open
Purpose: The purpose of the WU-CDTR pilot and feasibility program is to catalyze innovative research aimed at reducing the burden of diabetes. A priority of the program is to attract, retain, and develop early-stage investigators conducting diabetes translation research. The pilot and feasibility program focuses on T2-T4 translational research defined as ‘translating interventions and approaches that have demonstrated efficacy into real-world healthcare settings and communities, with an emphasis on reach, sustainability, and potential for widespread implementation’.
Two levels of funding are available for applicants:
- Pilot Grants: provide up to $50,000 direct costs for one year to facilitate the planning of a new clinical and/or translational research project.
- Small Projects (accepted on a rolling basis): This $5,000 funding opportunity will support highly-focused data collection, secondary- or other analyses relevant to the WU-CDTR mission. Small project application can be found here.
Application Timeline
| Applications Open: | October 23, 2025 |
| Letter of Intent Due: | December 8, 2025 |
| Full Proposals Due: | January 12, 2026 |
| Earliest Project Start Date: | April 1, 2026 |
Need assistance developing your proposal? Contact us at cdtr@wustl.edu